Literature DB >> 12152982

Fresh osteochondral allografts.

William D Bugbee1.   

Abstract

Fresh osteochondral allografts have a long clinical history and have demonstrated use in a wide spectrum of knee joint pathology. The allografting procedure takes advantage of the unique characteristics of osseous and chondral tissue components. Transplanted bone is readily incorporated by the host while the articular cartilage survives transplantation. Allografts have demonstrated >75% clinical success in the treatment of focal femoral condyle lesions due to trauma, chondral injury, osteochondral trauma, osteochondritis dissecans, avascular necrosis, and post-traumatic reconstruction. Fresh allografts also are finding an increasing role in the salvage of difficult cases that have failed other cartilage procedures, and particularly in individuals who are believed to be too young and active for joint arthroplasty. Further refinements in the technical aspects of the allografting procedure, as well as further understanding of the biology of osteochondral allografts, should lead to improved clinical outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12152982

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  38 in total

1.  The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage.

Authors:  H Davis Adkisson; James A Martin; Richard L Amendola; Curt Milliman; Kelsey A Mauch; Arbindra B Katwal; Mitchell Seyedin; Annuziato Amendola; Philip R Streeter; Joseph A Buckwalter
Journal:  Am J Sports Med       Date:  2010-04-27       Impact factor: 6.202

Review 2.  Management of knee articular cartilage injuries in athletes: chondroprotection, chondrofacilitation, and resurfacing.

Authors:  Iain R Murray; Michael T Benke; Bert R Mandelbaum
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-07       Impact factor: 4.342

3.  The use of autologous chondrocyte implantation following and combined with anterior cruciate ligament reconstruction.

Authors:  A A Amin; W Bartlett; C R Gooding; M Sood; J A Skinner; R W J Carrington; T W R Briggs; G Bentley
Journal:  Int Orthop       Date:  2005-12-01       Impact factor: 3.075

4.  The use of osteochondral allografts in the management of cartilage defects.

Authors:  Marco Demange; Andreas H Gomoll
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

5.  Open traumatic osteochondral fracture of the femoral medial condyle and trochlea treated by mosaicplasty: a case report at 11-year follow-up.

Authors:  Christian Carulli; Fabrizio Matassi; Stefano Soderi; Lorenzo Nistri; Roberto Civinini; Massimo Innocenti
Journal:  HSS J       Date:  2014-08-29

6.  Fresh Osteochondral Allograft Transplantation for Fractures of the Knee.

Authors:  Guilherme C Gracitelli; Luis Eduardo Passarelli Tirico; Julie C McCauley; Pamela A Pulido; William D Bugbee
Journal:  Cartilage       Date:  2016-07-07       Impact factor: 4.634

Review 7.  [Attitude towards organ and tissue donation in Europe : Prerequisite for osteochondral allograft treatment].

Authors:  S Schmidt; A Schulte; S Schwarz; N Hofmann; S Tietz; M Boergel; S U Sixt
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

8.  Effects of dexamethasone on the functional properties of cartilage explants during long-term culture.

Authors:  Liming Bian; Aaron M Stoker; Kevin M Marberry; Gerard A Ateshian; James L Cook; Clark T Hung
Journal:  Am J Sports Med       Date:  2009-12-03       Impact factor: 6.202

9.  Do fresh osteochondral allografts successfully treat femoral condyle lesions?

Authors:  Yadin D Levy; Simon Görtz; Pamela A Pulido; Julie C McCauley; William D Bugbee
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

10.  Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts.

Authors:  Andrea L Pallante; Won C Bae; Albert C Chen; Simon Görtz; William D Bugbee; Robert L Sah
Journal:  Am J Sports Med       Date:  2009-10-27       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.